chrisvoncsefalvay/vaers-outcomes huggingface dataset:
19 yro f presented with syncope. loss of consciousness after recieving vaccination. pt was pale cold and clammy. pt was brought ot evaluation are and assessed. pt vitasl were taken. pt regained conciousness during trasnport to evaluation area. pt was hypotensive bp 65/43 hr 53 spo2 95% rr 20 pt was provided cold water. pt was placed on ems crew 4 lead ekg. pt apperaed to have normal sinus rhythm.  pt vitaqls improved over a short period of time under ems monitoring. fire ems was called to transport patient to er dept. pt final vital set was 116/70 hr 65 spo2 100% ems arrived and pt care wa trasnfred to fire ems.
pt recvd vax in 1990 & 1992 recvd another 3 doses w/no response; OCT93 devel indigestion; short time later devel severe jaundice & gained 40 pounds, presumed to be fluid in abdo; MD who examined state died of fulminant overwhelming hep B i;
I experienced fainting, EMT arrived and found irregular heart beat. I went to the local hospital and I was in over night. I was diagnosed with Atrial fibrillation, I was placed on new prescriptions. then I went to cardio version to shot the heart to normal rythum.  Since then I have been in normal rhythm.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/3/2022 Discharge Date: Oct 5, 2022  PRESENTING PROBLEM: Hypoxia [R09.02] Acute on chronic respiratory failure with hypercapnia [J96.22] Dementia, unspecified dementia severity, unspecified dementia type, unspecified whether behavioral, psychotic, or mood disturbance or anxiety [F03.90] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is a 75 y.o. male with medical history significant for paroxysmal atrial fibrillation on Eliquis, type 2 diabetes mellitus not insulin dependent, chronic diastolic CHF, hypertension, dyslipidemia, and dementia who presented to the ED for evaluation of altered mentation and hypoxia. At the facility, the patient was noted be hypoxic and was placed on 3L of oxygen. In th ED, his O2 sats were at hight 90s on 2L of oxygen. He was afebrile. CT head was negative for acute process. Labs were significant for WBC 12.44,  lactic acid 2.1. VBG with normal pH, pCO2 83, bicarb 45. COVID-19 PCR was  positive.  CXR was negative for acute infiltrate or consolidation. The patient was started on oral Decadron. He was admitted for further evaluation and management.    The patient was found to have acute hypoxic respiratory insufficiency.  He was given Decadron 6 mg orally daily.  The patient was weaned from 2 L of oxygen to room air.  His respiratory status was monitored closely.   On the day of discharge, the patient denied any chest pain or shortness of breath.  He denied any cough, fever or chills.  No nausea, vomiting or abdominal pain.  The patient was tolerating diet.  His mentation was back to baseline he was oriented x2.  His vital signs have been stable.  Complete blood count was significant for white blood cell count of 19.38.  Leukocytosis was most likely secondary to steroids.  The patient should have a follow-up complete blood count in 2-3 days.  The patient was discharged to his clinic in stable medical condition.
Client states that after waiting the 30 minutes following her  vaccine, on the drive home, her tongue start swelling .  She immediately took an over the counter 24 hour non drowsy allergy medication and she was soon fine. No additional treatment needed.
She felt tired after receiving her first dose of Comirnaty; She felt nauseas after receiving her first dose of Comirnaty; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID:  A female patient received BNT162b2 (COMIRNATY), in Aug2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "She felt tired after receiving her first dose of Comirnaty"; NAUSEA (non-serious), outcome "unknown", described as "She felt nauseas after receiving her first dose of Comirnaty". Additional information: In Aug2021, respondent received first dose of Comirnaty, when she returned for her second dose she was given a choice of brand for her second dose of the vaccine and selected Moderna because she felt nauseas and tired after receiving her first dose of Comirnaty. Reporter considered event caused by suspect product. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a physician via field representative refers to a 13 year old female patient with amoxicillin (manufacturer unknown) allergy. The patient's historical drug included BCG vaccine (manufacturer unknown), received when 10 months old. On 15-MAR-2014 the patient was vaccinated with GARDASIL (lot # J015378, expiry date: 09-APR-2016). Concomitant medications were none. On 17-MAY-2014 the patient was vaccinated with second dose of GARDASIL. Approximately on 19-MAY-2014 (reported as 48 hours later), the patient's arm blew up and got inflamed at the site where the patient previously received a BCG vaccine (manufacturer unknown). Also reported as patient experienced injection site redness after receiving GARDASIL. The physician reported that the patient was an adopted child, who received a routine BCG vaccine (manufacturer unknown) in a foreign country. The physical also reported that in this country everyone gets BCG vaccine (manufacturer unknown). It was reported that the patient was administered BCG vaccine (manufacturer unknown) in another foreign country in the same arm prior to receiving GARDASIL. When 12 months of old the patient had PPD and a PPD response, which was a 10 by 10 millimeter (mm) area at the site of the PPD and the patient had a negative chest x-ray, 3 months later on an unspecified date, the patient had another PPD test and developed another PPD response, which was a 7 by 10 mm area at the PPD site. The physician mentioned that the patient did not receive any treatment. The patient had another PPD test on 15-NOV-2004 which was negative. The outcome of injection site redness and her arm blew up and got inflamed at the site was reported as recovering/resolving. The causality was not reported. The patient sought medical attention by visiting the physician's office. Additional information has been requested.
Patient received vaccine at 1153am in Left Deltoid, walked 20feet to observation area to wait 15 minutes in an armchair with arms under observation of staff. Was alert until 1156am when husband alerted staff that she was feeling very light-headed and nauseated. Pharmacist rushed over with hand-fan, but noticed Patient had started to become unresponsive. 911 Emergency response activated, ambulance on route. Pharmacist noted open eyes, glassy, there was no response to voice. She was sitting stable in chair husband and pharmacist at side. Pharmacist noted normal breathing and pulse. She was warm and sweaty to the touch. We kept talking to her, keeping the fan on her to keep her cool. Purse strap was removed from around her shoulders. Pulse and breathing still normal. She then came out of the syncope episode at 1159am. She was alert and oriented to time/place/person/self. Color returned to normal. Emergency services arrived approximately 3-4 minutes later. She was advised that it was a syncope episode that should be followed up at hospital/urgent care. She signed AMA with emergency ambulance services. She stayed in pharmacy under care of pharmacy support and store staff with water/fan staying seated whole time for additional 30 or so minutes until she and husband elected to leave the store.
This spontaneous report as received from a healthcare worker nurse refers to a 37 year old male patient. On 06-SEP-2013, the patient was vaccinated with the first dose of RECOMBIVAX HB (lot # H010965, Exp date 01-JUN-2014), injection "10 Y", 1.0 ml, intramuscular. On 31-OCT-2013, the patient was vaccinated with the second dose of RECOMBIVAX HB (lot # reported as J003580, Exp date 07-NOV-2014), injection "10 Y", 1.0 ml, intramuscular. On 07-NOV-2013, serologic testing did not show any antibody. No treatment was given for the events. No adverse effect reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
three fingers of my left hand went numb and the same happened with two toes; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (three fingers of my left hand went numb and the same happened with two toes) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced HYPOAESTHESIA (three fingers of my left hand went numb and the same happened with two toes). On 01-May-2021, HYPOAESTHESIA (three fingers of my left hand went numb and the same happened with two toes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included Medication for bipolarity for an unknown indication. No treatment medication provided 1st dose - Expiration date: not provided 2nd dose - Expiration date: not provided. Case crosslinked with case number MOD21-104844
got imovax a month through his gluteal region, with no reported adverse event; Initial information received on 17-Aug-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves an unknown age male patient who got imovax a month through his gluteal region, with no reported adverse event while receiving vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date the patient got imovax a month through his gluteal region, with no reported adverse event (incorrect route of product administration) (latency: same day) following the administration of RABIES (HDC) VACCINE.. The product was to be used for immunization  He found out by reading the prescribing information that it was not supposed to given at that site  Action taken : not applicable.  Outcome: unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Dose 3; Dose 3; I felt my arm was sore/achy arm and shoulder; I felt a little foggy/little bit off down/she again got a foggy head/feeling really bad; running a fever/fever of 100.8; headache/bad headache; I just feel dizzy/light headed; Off balance; Severe diarrhea; Feeling fatigued and jet lagged; she was feeling fatigued and jet lagged; she hadn't slept well the night before; achy arm and shoulder; This is a spontaneous report from contactable nurse. This 73-year-old female nurse (Patient) reported for herself that:  A 73-years-old female patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: FC3183), dose 3 via an unspecified route of administration on 23Sep2021 (73-year-old at the time of vaccination) as dose 3 (Booster), single for covid-19 immunisation. Medical history included, ongoing hypertension and cardiac disorder. The historical vaccine includes bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: unknown), dose 1 via an unspecified route of administration as dose 1, single for covid-19 immunisation and bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: unknown), dose 2 via an unspecified route of administration as dose 2, single for covid-19 immunisation. The patient's concomitant medications were not reported. Consumer stated, she got the Covid booster vaccine dose Pfizer booster one week ago today and for about 10 hours-12 hours she felt her arm was sore and she felt a little foggy you know just a little bit off down and she was sure normal side effects and then she have been fine until today and then around noon she started with the same symptoms but worse running a fever, she just feel dizzy, headache, light headed up balance. On an unspecified date in 2021, the patient underwent lab tests and procedures which included body temperature: 100.8. patient stated she got the first 2 vaccines, and then last Thursday she got the Covid Booster, and it had been 6 months and a week since the second vaccine. patient reported that about 3 hours after she had an achy arm and shoulder and she was a little foggy, the usual what she would expect, so she took Tylenol and she was fine the next day. patient stated then, one week later she again got a foggy head, was off balance, had severe diarrhea and a bad headache, and fever of 100.8. patient stated she just felt the same way as right after the booster, even though she had no symptoms for that week. patient stated like she said, it felt that same way as after the vaccine with that foggy feeling and being off balance, except more severe. patient stated she went in yesterday for a follow up exam, she seen them every 6 months because she has high blood pressure and cardiac issues. Patient stated she was feeling fatigued and jet lagged, she hadn't slept well the night before, but on her way home, she started feeling really bad, and she was running a fever. Patient stated her doctor doesn't know about this. Patient stated she was just curious if she could be re-having side effects, and she was wondering if she didn't get it too soon. The outcome for all events was unknown.    Follow-up attempts completed. No further information expected.
This case was reported by a consumer and described the occurrence of urticaria in a 38 year old male who received hepatitis B vaccine recombinant (Engerix-B) for prophylaxis.  A physician or other health care professional has not verified this report.  The pt's medical history, concurrent conditions and concurrent medications were not reported.  On 09/24/2003 the pt received the first dose of Engerix-B (Lot ENG5387B6).  Approximately 10 days post-immunization, on 10/04/03, the pt experienced "burning muscle tissue" and rash.  The rash spread all over his body including his back and scalp.  The pt was evaluated by a physician who told the pt it was angioedema, but subsequently diagnosed urticaria. The pt was treated with oral ranitidine (Zantac) and oral diphenhydramine (Benadryl).  The events were unresolved as of 11/07/03.
Immediately after receiving IM influenza vaccine patient felt lightheaded. She quickly developed left-sided body numbness, difficulty breathing, inability to walk/talk.
chills; body ache; headache; Soreness at injection site started approx 2000hrs on 13Oct2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 13Oct2021 14:15 (Lot number: EW0217) at the age of 44 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ADVAIR; SINGULAIR; LOSARTAN. Past drug history included: Theophylline, reaction(s): "Known allergies: Theophylline", notes: Known allergies: Theophylline. Vaccination history included: Bnt162b2 (lot number: EL3247, dose administration route: Intramuscular, dose number: 2, dose vaccine location: Left arm), administration date: 17Feb2021, when the patient was 44 years old, for Covid-19 Immunization; Bnt162b2 (lot number: EL3247, dose administration route: Intramuscular, dose number: 1, dose vaccine location: Left arm.), administration date: 27Jan2021, when the patient was 44 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 13Oct2021 20:00, outcome "recovering", described as "Soreness at injection site started approx 2000hrs on 13Oct2021"; CHILLS (non-serious) with onset 14Oct2021 17:30, outcome "recovering", described as "chills"; PAIN (non-serious) with onset 14Oct2021 17:30, outcome "recovering", described as "body ache"; HEADACHE (non-serious) with onset 14Oct2021 17:30, outcome "recovering", described as "headache". Therapeutic measures were not taken as a result of vaccination site pain, chills, pain, headache.  Additional information: No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination.    No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 15-JUL-2015, the patient was vaccinated with an improperly stored dose of M-M-R II lot # K016154 with exp. 24-SEP-2016, (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Extreme (R) arm swelling post shingrix #1 given on 8-6-2019 that continued thru 8-13-19
1 week after getting the first shot of the Moderna Covid vaccine, I am experiencing swelling, itchiness, redness, and heat at the vaccine site.  The swollen area is about 7 cm in diameter.  I first noticed itchiness at the vaccination site (my left shoulder) this morning.  I was aware of itchiness twice more throughout the day.  And my shoulder felt thick and itchy in the evening too, so I finally looked at it in the mirror and saw that it was red and swollen.
A non-serious, spontaneous report of "sick with fever, coughing, sinusitis and allergies since getting FLUMIST in October" has been received from a 37-year-old male consumer subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The patient received FLUMIST on 26-Oct-2009. Since 28-Oct-2009, the patient has been sick with fever, cough, sinusitis and allergies. The adverse events have not resolved.
CoughWheeze, Palpitations, Angina & Tachycardia Narrative:  Employee followed up for vaccine reaction claim in employee occ health on 11/24/21 and 11/29/21. Reports dyspnea on exertion, cough and intermittent chest pain denies chest pain at present. Recommended ED visit, however he declined this. Denies cardiac disease history. On exam BP mildly elevated 137/88 apical rate 90, regular rhythm no friction rub. ECG showed nsr with pvcs and rate 80s. Troponin BNP CBC and CMP normal findings. COVID tested neg. CRP 1.3. CXR showed enlarged cardiac silloutte, lungs clear. Unclear if enlarged cardiac silloutte was present previously, no imaging to compare previously. Employee will follow up with worker's comp provider, pmd and request referral to cardiologist
mild case of Bell's palsy (diagnosed) post 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (mild case of Bell's palsy (diagnosed) post 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BELL'S PALSY (mild case of Bell's palsy (diagnosed) post 2nd dose). At the time of the report, BELL'S PALSY (mild case of Bell's palsy (diagnosed) post 2nd dose) outcome was unknown.            No concomitant drug details were reported. No treatment details were reported.  Company comment: This Spontaneous case concerns a patient of unknown age and gender with no reported medical history, who experienced the expected, non-serious and AESI of Bell's palsy. The events occurred after receiving the first dose of mRNA-1273 vaccine. Patient experienced a mild case of Bell's palsy which was diagnosed at the hospital emergency room approximately two months after receiving the second dose of mRNA-1273 vaccine. The rechallenge is not applicable, as no additional dose information was disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This Spontaneous case concerns a patient of unknown age and gender with no reported medical history, who experienced the expected, non-serious and AESI of Bell's palsy. The events occurred after receiving the first dose of mRNA-1273 vaccine. Patient experienced a mild case of Bell's palsy which was diagnosed at the hospital emergency room approximately two months after receiving the second dose of mRNA-1273 vaccine. The rechallenge is not applicable, as no additional dose information was disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
mom noted start of urticarial rash within a couple of hours of administration, rash pesists 10+ days
Pain in right upper arm increasing in the late afternoon on 11/03. Pain was most noticeable on inside of right upper arm where pneumonia vaccine was given. Naproxen taken and pain mostly relieved. On the morning of 11/04, mild pain still experienced. Site examination showed redness on right arm from below injection site to the inner side of the arm where there is a hard red site.  I went to care center and was diagnosed as having a reaction to the pneumonia vaccine and prescribed prednisone and Benadryl.
broke out into hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (broke out into hives) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028220A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced URTICARIA (broke out into hives). The patient was treated with FLUOCINONIDE at an unspecified dose and frequency. At the time of the report, URTICARIA (broke out into hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Reporter did not allow further contact
This spontaneous report as received from a registered nurse refers to an unspecified number of patient of unknown age and gender. Patients medical history and current conditions were not provided. On an unknown date since 26-NOV-2014, the patients were vaccinated with an incorrect storage doses of RECOMBIVAX HB (lot #, expiration date, dose and route were not reported). No concomitant medication was reported. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.